2023 - Research.com Medicine in United States Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in United States Leader Award
2004 - Libin/AHFMR Prize in Cardiovascular Research
2003 - Distinguished Scientist Award, American Heart Association
2002 - King Faisal Prize
2001 - Warren Alpert Foundation Prize For their pioneering work in cardiovascular research which has dramatically reduced the mortality rate for heart attacks.
1989 - Fellow of the American Association for the Advancement of Science (AAAS)
1981 - James B. Herrick Award for Outstanding Achievement in Clinical Cardiology, American Heart Association
1974 - Member of the National Academy of Sciences
1974 - Member of the National Academy of Medicine (NAM)
1973 - Fellow of the American Academy of Arts and Sciences
Member of the Association of American Physicians
His scientific interests lie mostly in Internal medicine, Cardiology, Myocardial infarction, Heart failure and TIMI. Within one scientific family, Eugene Braunwald focuses on topics pertaining to Surgery under Internal medicine, and may sometimes address concerns connected to Placebo. Eugene Braunwald combines topics linked to Anesthesia with his work on Cardiology.
His Myocardial infarction research focuses on Pravastatin and how it connects with Atorvastatin. The study incorporates disciplines such as Heart disease and Renal function in addition to Heart failure. His TIMI research includes themes of Platelet aggregation inhibitor, Aspirin and Fibrinolytic agent.
Internal medicine, Cardiology, Myocardial infarction, TIMI and Heart failure are his primary areas of study. His study in Internal medicine is interdisciplinary in nature, drawing from both Anesthesia and Surgery. His Cardiology study frequently draws connections to other fields, such as Blood pressure.
His Myocardial infarction study frequently links to adjacent areas such as Coronary artery disease. His TIMI study incorporates themes from Framingham Risk Score, Fibrinolysis, Atrial fibrillation, Hazard ratio and Aspirin. Eugene Braunwald interconnects Diabetes mellitus, Endocrinology and Intensive care medicine in the investigation of issues within Heart failure.
Eugene Braunwald focuses on Internal medicine, Cardiology, TIMI, Myocardial infarction and Heart failure. Eugene Braunwald conducts interdisciplinary study in the fields of Internal medicine and In patient through his works. The concepts of his Cardiology study are interwoven with issues in Diabetes mellitus, Placebo and Randomized controlled trial, Surgery.
His studies deal with areas such as Anesthesia, Framingham Risk Score, Rivaroxaban, Vorapaxar and Ticagrelor as well as TIMI. His research integrates issues of Aspirin and Clinical endpoint in his study of Myocardial infarction. His studies in Heart failure integrate themes in fields like Valsartan and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Harrison's Principles of Internal Medicine
edotir's Eugene Braunwald....
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
F. M. Sacks;M. A. Pfeffer;L. A. Moye;J. L. Rouleau.
The New England Journal of Medicine (1996)
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina)
Eugene Braunwald;Elliott M. Antman;John W. Beasley;Robert M. Califf.
Bariatric surgery: a systematic review and meta-analysis.
Henry Buchwald;Yoav Avidor;Eugene Braunwald;Michael D. Jensen.
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
Stephen D. Wiviott;Eugene Braunwald;Carolyn H. McCabe;Gilles Montalescot.
The New England Journal of Medicine (2007)
EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION. RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL
Marc A. Pfeffer;Eugene Braunwald;Lemuel A. Moyé;Lofty Basta.
The New England Journal of Medicine (1992)
Heart Disease: A Textbook of Cardiovascular Medicine
Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Christopher P. Cannon;Eugene Braunwald;Carolyn H. McCabe;Daniel J. Rader.
The New England Journal of Medicine (2004)
Edoxaban versus warfarin in patients with atrial fibrillation
Robert P. Giugliano;Christian T. Ruff;Eugene Braunwald;Sabina A. Murphy.
The New England Journal of Medicine (2013)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T Ruff;Robert P Giugliano;Eugene Braunwald;Elaine B Hoffman.
The Lancet (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: